Eisai

Pharma

Merck-Kelun, China deal wisdom, Takeda—Fierce Pharma Asia

Merck and Kelun's sac-TMT reported three positive phase 3s. Experts talk useful tools in China dealmaking. Takeda was hit with a pay-for-delay verdict.

Angus Liu May 22, 2026 8:53am

Eisai's push toward blockbuster Leqembi sales gains steam

May 15, 2026 11:35am

Merck, Zai Lab, Kailera-Hengrui—Fierce Pharma Asia

Apr 24, 2026 8:22am

Lilly, Pfizer-Sciwind, Astellas—Fierce Pharma Asia

Mar 13, 2026 8:05am

Eisai taps Pokémon app for healthy sleep awareness collab

Mar 12, 2026 11:40am

Graphic image of a compass above an unfolded map Orange background color

Eisai’s Kompass points the way to kidney cancer support

Feb 26, 2026 11:45am